Improved Outcomes of Hematopoietic Stem Cell Transplantation in Patients With Infantile Malignant Osteopetrosis Using Fludarabine-Based Conditioning
- 20 October 2015
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 63 (3) , 535-540
Abstract
Background Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for infantile malignant osteopetrosis (IMO), but is associated with a high incidence of adverse outcomes. In this study, we present our experience with HSCT for IMO patients comparing different types of conditioning regimens. Methods Thirty-eight patients with IMO (aged from 1 month to 6 years, median 0.66 years) who underwent allogeneic HSCT from 1983 in our hospital were included in this retrospective study. Fludarabine-based conditioning regimens were used in 26 patients and 12 patients were transplanted using other conditioning regimens. Results The overall survival after conditioning with fludarabine was 96% (25/26) versus 58% (7/12) for the alternative regimens (P = 0.004), with significantly fewer adverse effects including hypercalcemia and veno-occlusive disease of liver. All patients who survive are clinically well. Conclusions We conclude that fludarabine-based conditioning regimens are safe and effective in patients with IMO, improving morbidity and mortality related to HSCT.Keywords
This publication has 43 references indexed in Scilit:
- RANK-dependent autosomal recessive osteopetrosis: Characterization of five new cases with novel mutationsJournal of Bone and Mineral Research, 2011
- Diseases Affecting Bone Quality: Beyond OsteoporosisClinical Orthopaedics and Related Research, 2011
- Hypercalcemia and altered biochemical bone markers in post‐bone marrow transplantation osteopetrosis: A case report and literature reviewPediatric Transplantation, 2011
- Role of NF-κB in the skeletonCell Research, 2010
- Functions of nuclear factor κB in boneAnnals of the New York Academy of Sciences, 2010
- OsteopetrosisOrphanet Journal of Rare Diseases, 2009
- Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosisExperimental Hematology, 2009
- Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effectEuropean Journal of Human Genetics, 2009
- Bone marrow transplantation for autosomal recessive osteopetrosis A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation GroupThe Journal of Pediatrics, 1994
- Successful Bone-Marrow Transplantation for Infantile Malignant OsteopetrosisNew England Journal of Medicine, 1980